GANTANOL Drug Patent Profile
✉ Email this page to a colleague
When do Gantanol patents expire, and what generic alternatives are available?
Gantanol is a drug marketed by Roche and is included in two NDAs.
The generic ingredient in GANTANOL is sulfamethoxazole. There are twenty-seven drug master file entries for this compound. Additional details are available on the sulfamethoxazole profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for GANTANOL?
- What are the global sales for GANTANOL?
- What is Average Wholesale Price for GANTANOL?
Summary for GANTANOL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 163 |
| Patent Applications: | 4,023 |
| DailyMed Link: | GANTANOL at DailyMed |
US Patents and Regulatory Information for GANTANOL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Roche | GANTANOL | sulfamethoxazole | SUSPENSION;ORAL | 013664-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Roche | GANTANOL | sulfamethoxazole | TABLET;ORAL | 012715-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Roche | GANTANOL-DS | sulfamethoxazole | TABLET;ORAL | 012715-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
